| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 12,291 | 21,117 | 8,420 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 12,291 | 21,117 | 8,420 | | | Operating Expenses | | Research Development | 22,140 | 27,854 | 28,820 | | Selling General and Administrative | 5,748 | 5,940 | 5,907 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (15,597) | (12,677) | (26,307) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 972 | 1,960 | 1,712 | | Earnings Before Interest And Taxes | (14,625) | (10,717) | (24,595) | | Interest Expense | 190 | 168 | 213 | | Income Before Tax | (14,815) | (10,885) | (24,808) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,815) | (10,885) | (24,808) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,815) | (10,885) | (24,808) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,815) | ($10,885) | ($24,808) |
|
0.63% Nasdaq 
0.03%
Income Statement
